Last reviewed · How we verify
Meprane Dipropionate — Competitive Intelligence Brief
unknown
methestrol dipropionate
Other
Live · refreshed every 30 min
Target snapshot
Meprane Dipropionate (methestrol dipropionate). Meprane Dipropionate works by binding to and activating specific receptors in the body, leading to changes in gene expression and cellular function.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Meprane Dipropionate TARGET | methestrol dipropionate | unknown | methestrol dipropionate |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (methestrol dipropionate class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Meprane Dipropionate CI watch — RSS
- Meprane Dipropionate CI watch — Atom
- Meprane Dipropionate CI watch — JSON
- Meprane Dipropionate alone — RSS
- Whole methestrol dipropionate class — RSS
Cite this brief
Drug Landscape (2026). Meprane Dipropionate — Competitive Intelligence Brief. https://druglandscape.com/ci/methestrol-dipropionate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing